Matthew Harrison
Stock Analyst at Susquehanna
(3.49)
# 874
Out of 5,147 analysts
711
Total ratings
50%
Success rate
4.31%
Average return
Main Sectors:
Stocks Rated by Matthew Harrison
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| R Ryder System | Maintains: Positive | $235 → $250 | $221.56 | +12.84% | 2 | Feb 13, 2026 | |
| REGN Regeneron Pharmaceuticals | Maintains: Equal-Weight | $768 → $769 | $781.67 | -1.62% | 59 | Feb 2, 2026 | |
| INSM Insmed | Maintains: Equal-Weight | $157 → $162 | $149.33 | +8.48% | 20 | Jan 30, 2026 | |
| GILD Gilead Sciences | Maintains: Overweight | $151 → $150 | $148.95 | +0.70% | 44 | Jan 13, 2026 | |
| MRNA Moderna | Maintains: Equal-Weight | $30 → $28 | $53.57 | -47.73% | 27 | Dec 12, 2025 | |
| LEGN Legend Biotech | Maintains: Overweight | $83 → $50 | $19.00 | +163.16% | 14 | Dec 12, 2025 | |
| BIIB Biogen | Maintains: Equal-Weight | $149 → $156 | $191.82 | -18.67% | 56 | Dec 12, 2025 | |
| ARGX argenx SE | Maintains: Overweight | $1,070 → $1,110 | $766.92 | +44.73% | 27 | Dec 4, 2025 | |
| PHVS Pharvaris | Maintains: Overweight | $37 → $41 | $28.39 | +44.42% | 16 | Dec 4, 2025 | |
| ZNTL Zentalis Pharmaceuticals | Maintains: Equal-Weight | $8 → $4 | $2.39 | +67.36% | 5 | Nov 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $104 → $98 | $61.73 | +58.76% | 23 | Oct 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $33 → $30 | $21.18 | +41.64% | 13 | Aug 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $6 → $4 | $0.35 | +1,046.13% | 6 | Aug 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $460 → $439 | $496.83 | -11.64% | 41 | Aug 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $15 → $20 | $16.76 | +19.33% | 38 | Jul 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $6.2 → $6 | $4.68 | +28.21% | 10 | Apr 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $15 → $5 | $0.56 | +790.00% | 5 | Mar 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $56 | $41.07 | +36.35% | 2 | Feb 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $57 → $55 | $30.96 | +77.65% | 2 | Jan 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underweight | $10 → $3 | $2.43 | +23.46% | 10 | Nov 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $8 → $11 | $26.86 | -59.05% | 9 | Jun 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Equal-Weight | $7 | $2.20 | +218.18% | 18 | May 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $32 | $29.44 | +8.70% | 27 | Mar 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $21 → $19 | $4.62 | +311.26% | 3 | Aug 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $2 → $1 | $1.69 | -40.83% | 3 | Mar 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $13 → $10 | $22.96 | -56.45% | 9 | Mar 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Equal-Weight | $27 → $8 | $8.38 | -4.53% | 9 | Feb 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $57 → $44 | $33.66 | +30.72% | 28 | Feb 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $15 → $13 | $4.21 | +208.79% | 3 | Jan 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $140 → $80 | $24.00 | +233.33% | 4 | Jan 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $100 → $60 | $4.52 | +1,227.43% | 4 | Jan 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $203 → $216 | $110.23 | +95.95% | 8 | Jan 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $7 → $5 | $4.10 | +21.95% | 13 | Jan 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $7 → $5 | $2.96 | +68.92% | 6 | Jan 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $178 → $182 | $232.08 | -21.58% | 8 | Dec 6, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $12 → $9 | $26.80 | -66.42% | 13 | Nov 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $279 → $282 | $388.16 | -27.35% | 38 | Nov 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $220 → $210 | $332.92 | -36.92% | 7 | Oct 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $55 → $52 | $27.65 | +88.07% | 5 | May 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $175 → $173 | $248.43 | -30.36% | 3 | Apr 6, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $156 → $120 | $23.39 | +413.04% | 17 | Feb 1, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $145 → $148 | $11.52 | +1,184.72% | 19 | Jan 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $88 → $82 | $123.82 | -33.77% | 4 | Nov 29, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $71 → $66 | $62.37 | +5.82% | 4 | Oct 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $43 → $39 | $4.53 | +760.93% | 4 | Aug 18, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $51 → $46 | $46.21 | -0.45% | 1 | Aug 16, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $33 → $35 | $7.29 | +380.11% | 1 | Aug 16, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $207 → $275 | $1,051.99 | -73.86% | 2 | Aug 5, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $19 | $2.95 | +544.07% | 1 | Jun 24, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $67 → $62 | $9.04 | +585.84% | 12 | Mar 8, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $16 → $17 | $16.80 | +2.68% | 3 | Feb 24, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $89 → $83 | $101.27 | -18.04% | 1 | Jan 6, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Equal-Weight | $10 | $62.22 | -83.93% | 4 | Sep 10, 2018 |
Ryder System
Feb 13, 2026
Maintains: Positive
Price Target: $235 → $250
Current: $221.56
Upside: +12.84%
Regeneron Pharmaceuticals
Feb 2, 2026
Maintains: Equal-Weight
Price Target: $768 → $769
Current: $781.67
Upside: -1.62%
Insmed
Jan 30, 2026
Maintains: Equal-Weight
Price Target: $157 → $162
Current: $149.33
Upside: +8.48%
Gilead Sciences
Jan 13, 2026
Maintains: Overweight
Price Target: $151 → $150
Current: $148.95
Upside: +0.70%
Moderna
Dec 12, 2025
Maintains: Equal-Weight
Price Target: $30 → $28
Current: $53.57
Upside: -47.73%
Legend Biotech
Dec 12, 2025
Maintains: Overweight
Price Target: $83 → $50
Current: $19.00
Upside: +163.16%
Biogen
Dec 12, 2025
Maintains: Equal-Weight
Price Target: $149 → $156
Current: $191.82
Upside: -18.67%
argenx SE
Dec 4, 2025
Maintains: Overweight
Price Target: $1,070 → $1,110
Current: $766.92
Upside: +44.73%
Pharvaris
Dec 4, 2025
Maintains: Overweight
Price Target: $37 → $41
Current: $28.39
Upside: +44.42%
Zentalis Pharmaceuticals
Nov 12, 2025
Maintains: Equal-Weight
Price Target: $8 → $4
Current: $2.39
Upside: +67.36%
Oct 28, 2025
Maintains: Overweight
Price Target: $104 → $98
Current: $61.73
Upside: +58.76%
Aug 18, 2025
Maintains: Overweight
Price Target: $33 → $30
Current: $21.18
Upside: +41.64%
Aug 12, 2025
Maintains: Overweight
Price Target: $6 → $4
Current: $0.35
Upside: +1,046.13%
Aug 5, 2025
Maintains: Equal-Weight
Price Target: $460 → $439
Current: $496.83
Upside: -11.64%
Jul 29, 2025
Maintains: Equal-Weight
Price Target: $15 → $20
Current: $16.76
Upside: +19.33%
Apr 11, 2025
Maintains: Equal-Weight
Price Target: $6.2 → $6
Current: $4.68
Upside: +28.21%
Mar 12, 2025
Maintains: Overweight
Price Target: $15 → $5
Current: $0.56
Upside: +790.00%
Feb 18, 2025
Upgrades: Buy
Price Target: $56
Current: $41.07
Upside: +36.35%
Jan 31, 2025
Maintains: Buy
Price Target: $57 → $55
Current: $30.96
Upside: +77.65%
Nov 26, 2024
Downgrades: Underweight
Price Target: $10 → $3
Current: $2.43
Upside: +23.46%
Jun 21, 2024
Maintains: Equal-Weight
Price Target: $8 → $11
Current: $26.86
Upside: -59.05%
May 9, 2024
Upgrades: Equal-Weight
Price Target: $7
Current: $2.20
Upside: +218.18%
Mar 26, 2024
Maintains: Underweight
Price Target: $32
Current: $29.44
Upside: +8.70%
Aug 14, 2023
Maintains: Equal-Weight
Price Target: $21 → $19
Current: $4.62
Upside: +311.26%
Mar 27, 2023
Maintains: Underweight
Price Target: $2 → $1
Current: $1.69
Upside: -40.83%
Mar 3, 2023
Maintains: Underweight
Price Target: $13 → $10
Current: $22.96
Upside: -56.45%
Feb 28, 2023
Downgrades: Equal-Weight
Price Target: $27 → $8
Current: $8.38
Upside: -4.53%
Feb 27, 2023
Maintains: Equal-Weight
Price Target: $57 → $44
Current: $33.66
Upside: +30.72%
Jan 24, 2023
Maintains: Overweight
Price Target: $15 → $13
Current: $4.21
Upside: +208.79%
Jan 24, 2023
Maintains: Equal-Weight
Price Target: $140 → $80
Current: $24.00
Upside: +233.33%
Jan 24, 2023
Maintains: Equal-Weight
Price Target: $100 → $60
Current: $4.52
Upside: +1,227.43%
Jan 24, 2023
Maintains: Equal-Weight
Price Target: $203 → $216
Current: $110.23
Upside: +95.95%
Jan 24, 2023
Maintains: Equal-Weight
Price Target: $7 → $5
Current: $4.10
Upside: +21.95%
Jan 24, 2023
Maintains: Overweight
Price Target: $7 → $5
Current: $2.96
Upside: +68.92%
Dec 6, 2022
Maintains: Overweight
Price Target: $178 → $182
Current: $232.08
Upside: -21.58%
Nov 14, 2022
Maintains: Equal-Weight
Price Target: $12 → $9
Current: $26.80
Upside: -66.42%
Nov 4, 2022
Maintains: Overweight
Price Target: $279 → $282
Current: $388.16
Upside: -27.35%
Oct 28, 2022
Maintains: Equal-Weight
Price Target: $220 → $210
Current: $332.92
Upside: -36.92%
May 4, 2022
Maintains: Equal-Weight
Price Target: $55 → $52
Current: $27.65
Upside: +88.07%
Apr 6, 2022
Maintains: Equal-Weight
Price Target: $175 → $173
Current: $248.43
Upside: -30.36%
Feb 1, 2022
Maintains: Overweight
Price Target: $156 → $120
Current: $23.39
Upside: +413.04%
Jan 7, 2022
Maintains: Equal-Weight
Price Target: $145 → $148
Current: $11.52
Upside: +1,184.72%
Nov 29, 2021
Maintains: Equal-Weight
Price Target: $88 → $82
Current: $123.82
Upside: -33.77%
Oct 12, 2021
Maintains: Equal-Weight
Price Target: $71 → $66
Current: $62.37
Upside: +5.82%
Aug 18, 2021
Maintains: Overweight
Price Target: $43 → $39
Current: $4.53
Upside: +760.93%
Aug 16, 2021
Maintains: Equal-Weight
Price Target: $51 → $46
Current: $46.21
Upside: -0.45%
Aug 16, 2021
Maintains: Equal-Weight
Price Target: $33 → $35
Current: $7.29
Upside: +380.11%
Aug 5, 2021
Maintains: Overweight
Price Target: $207 → $275
Current: $1,051.99
Upside: -73.86%
Jun 24, 2021
Initiates: Buy
Price Target: $19
Current: $2.95
Upside: +544.07%
Mar 8, 2021
Maintains: Overweight
Price Target: $67 → $62
Current: $9.04
Upside: +585.84%
Feb 24, 2021
Maintains: Equal-Weight
Price Target: $16 → $17
Current: $16.80
Upside: +2.68%
Jan 6, 2020
Maintains: Equal-Weight
Price Target: $89 → $83
Current: $101.27
Upside: -18.04%
Sep 10, 2018
Assumes: Equal-Weight
Price Target: $10
Current: $62.22
Upside: -83.93%